Ranbaxy to sell Terapia’s liquid business
|
|
NEW DELHI: India, the largest pharmaceutical company Ranbaxy Laboratories is the distribution of the liquid at the hearing, the manufacturing unit of its subsidiary Romanian Terapia. The company is learnt to have, discussions with several global companies to sell the equipment, worth $ 15-20 million. While Ranbaxy Laboratories has initiated discussions with all the Indian companies, the pharmaceutical industry, experts say that few national companies in the markets want audience, syrups or drugs in Romania and Europe have a view on the capital. The sale of the unit is not likely not affect the turnover of Indian society in the region. The unit is located in Bucharest and liquids for the production of oral medications. Sources indicated that the decision backwardation profitable for sale a rationalization of production is in motion, for the production of the company with its principal operations in Kluez. In addition, the production of liquid is not the heart of the business area of Ranbaxy Laboratories. The company is expected to conclude the transaction by the end of this quarter. The Gurgaon-based Terapia company had acquired in 2006 for $ 324 million to identify and Romania as a strategic measure tap the European market. For fiscal 2007, Romania, a turnover of more than $ 100 million for the company. When contacted, a spokesman for companies has gone to comment. Romania is a low-cost, and with the goal of joining the European Union once it has become a gateway for generic drugs for business in the European market. Ranbaxy Laboratories is the reference in planning operations in Terapia and exports in the markets of Western Europe. Post acquisition, the company has invested approximately $ 10 million in Romania. Ranbaxy Laboratories, has tried its stronghold in the country. In collaboration with some Indian firms, the company has been integrated into the Schlachtgetümmel recover 53% of Romania’s participation in major SOEs Antibiotice drugs, currently being privatized. The privatization process has been moved for an indefinite period because of legal obstacles. |